Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Notable Labs
Special Reports
The 2024 Biotech Graveyard
Beware: ghosts of biotech’s past.
Gabrielle Masson
Oct 31, 2024 5:00am
Notable goes bankrupt, ending plans for Boehringer cancer drug
Oct 15, 2024 8:45am
Cell-focused Sana scoops first CSO—Chutes & Ladders
Aug 30, 2024 8:30am
After a tough year, VBL merges with Notable Labs
Feb 23, 2023 11:26am
Cardurion taps Takeda veteran Morabito as CMO—Chutes & Ladders
Jul 10, 2020 9:30am
Notable Labs launches rolling blood cancer trial to test its AI
Jan 22, 2020 8:20am
